1.	Study Comparing Isolated Pelvic Perfusion With TNF-a 0.3 mg and Melphalan 1.5 mg/kg Versus Standard Treatment in Patients With Non Resectable, Recurrent Gynaecologic or Digestive Pelvic Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 to 76 Sponsor: Other Protocol IDs: PIP2, CSET 1443, NCT00949039
2.	Topotecan in Combination With Gemcitabine in Patients With Platinum-Resistant Ovarian Carcinoma Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: CT/06.14, NCT00429559
3.	Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: CT/07.07, NCT00750386
4.	Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CAR\TAXHY, NCT00189566
5.	Conditioning Regimens and One or Two Autologous Peripheral Stem Cell Transplants in Treating Patients With Germ Cell Tumors Phase: Phase II Type: Treatment Status: Active Age: 10 to 69 Sponsor: NCI Protocol IDs: UMN-2006LS032, UMN-MT2005-21, UMN-0608M90586, NCT00432094
6.	Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Any age Sponsor: NCI Protocol IDs: CINJ-3330, NCT00161187
7.	Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-07044, 07-044, NCT00470366
8.	Phase I Study Using Sunitinib Plus Radiation Therapy for Cancer Patients Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 06C.549, NCT00437372
9.	Randomized, Double Blind, Placebo-Controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NYU 05-409, NCT00821652
10.	A Randomized, Open Label, Two Treatment, Two Period, Two Sequence, Single Dose, Crossover, Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection in Patients With Ovarian Cancer Phase: Phase I Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: DOX_2I_1476_09, NCT00862355
11.	Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: TAMC 3H04, NCT00160472
12.	Pharmacogenomics of Paclitaxel in Ovarian Cancer Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: WRAMC WU# 04-23009, NCT00415207
13.	Respiratory Tumor and Normal Tissue Motion Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: 2003-0962, NCT00415675
14.	Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: CHNT-RAPPER, EU-20798, RAPPER, NCT00601406
15.	Screening of Biomarkers on Endometrial Cancers Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 15 to 80 Sponsor: Other Protocol IDs: 200706001R, NCT00674349
16.	Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy Phase: No phase specified Type: Health services research, Treatment Status: Active Age: 21 and over Sponsor: Other Protocol IDs: 08-092, NCT00746018
17.	Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer Phase: No phase specified Type: Health services research, Natural history/Epidemiology, Supportive care, Treatment Status: Active Age: Over 18 Sponsor: NCI Protocol IDs: CHNMC-07007, 07007, NCT00804258
18.	Ultrasound Hyperthermia Therapy After Implant Radiation Therapy in Treating Patients With Urinary Tract Cancer, Gynecologic Cancer, or Head and Neck Cancer Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: UCSF-08992, 08992, H10778-32056, NCT00911079